Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists

The flexible hydrophobic ligand binding pocket (LBP) of estrogen receptor α (ERα) allows the binding of a wide variety of endocrine disruptors. Upon ligand binding, the LBP reshapes around the contours of the ligand and stabilizes the complex by complementary hydrophobic interactions and specific hydrogen bonds with the ligand. Here we present a framework for quantitative analysis of the steric and electronic features of the human ERα-ligand complex using three dimensional (3D) protein-ligand interaction description combined with 3D-QSAR approach. An empirical hydrophobicity density field is applied to account for hydrophobic contacts of ligand within the LBP. The obtained 3D-QSAR model revealed that hydrophobic contacts primarily determine binding affinity and govern binding mode with hydrogen bonds. Several residues of the LBP appear to be quite flexible and adopt a spectrum of conformations in various ERα-ligand complexes, in particular His524. The 3D-QSAR was combined with molecular docking based on three receptor conformations to accommodate receptor flexibility. The model indicates that the dynamic character of the LBP allows accommodation and stable binding of structurally diverse ligands, and proper representation of the protein flexibility is critical for reasonable description of binding of the ligands. Our results provide a quantitative and mechanistic understanding of binding affinity and mode of ERα agonists and antagonists that may be applicable to other nuclear receptors.

[1]  A. Bondi.  van der Waals Volumes and Radii , 1964 .

[2]  A. C. Lovesey.  Potential coenzyme inhibitors. 3. Some reactions of substituted nicotinamide and dihydronicotinamide derivatives. , 1969, Journal of medicinal chemistry.

[3]  E. Novikov,et al.  The specificity of the human uterine receptor. , 1979, Acta endocrinologica.

[4]  Harold A. Scheraga,et al.  Determination of net atomic charges using a modified partial equalization of orbital electronegativity method. 1. Application to neutral molecules as models for polypeptides , 1990 .

[5]  Harold A. Scheraga,et al.  An empirical method to calculate average molecular polarizabilities from the dependence of effective atomic polarizabilities on net atomic charge , 1993 .

[6]  A. Soto,et al.  Developmental effects of endocrine-disrupting chemicals in wildlife and humans , 1994 .

[7]  C. Dobson,et al.  Probing the Nature of Noncovalent Interactions by Mass Spectrometry. A Study of Protein−CoA Ligand Binding and Assembly , 1996 .

[8]  D M Sheehan,et al.  QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. , 1997, Endocrinology.

[9]  C D Humfrey,et al.  Reproductive health in humans and wildlife: are adverse trends associated with environmental chemical exposure? , 1997, The Science of the total environment.

[10]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[11]  John A. Katzenellenbogen,et al.  The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site , 1997, Steroids.

[12]  V. Giguère,et al.  Orphan nuclear receptors: from gene to function. , 1999 .

[13]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[14]  Q Xie,et al.  Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. , 2001, Chemical research in toxicology.

[15]  D. Bentrem,et al.  Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells. , 2002, The Journal of biological chemistry.

[16]  D. Bentrem,et al.  Structure-Function Relationships of the Raloxifene-Estrogen Receptor-α Complex for Regulating Transforming Growth Factor-α Expression in Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[17]  R. Russell,et al.  A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. , 2002, Molecular cell.

[18]  R. Hanson,et al.  Evaluation of 17α-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands , 2003, Steroids.

[19]  Nico P E Vermeulen,et al.  Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. , 2004, Journal of medicinal chemistry.

[20]  Ying Li,et al.  Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers. , 2005, Bioorganic & medicinal chemistry letters.

[21]  T. Willson,et al.  Structural basis for an unexpected mode of SERM-mediated ER antagonism. , 2005, Molecular cell.

[22]  Tsai-Wei Shen,et al.  A pharmacophore‐based evolutionary approach for screening selective estrogen receptor modulators , 2005, Proteins.

[23]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[24]  Andrzej Joachimiak,et al.  Structural plasticity in the oestrogen receptor ligand‐binding domain , 2007, EMBO reports.

[25]  M. Ammirati,et al.  The 2.0 Å crystal structure of the ERα ligand‐binding domain complexed with lasofoxifene , 2007, Protein Science.

[26]  B. Gerrits,et al.  Estrogen receptor–ligand complexes measured by chip‐based nanoelectrospray mass spectrometry: An approach for the screening of endocrine disruptors , 2007, Protein science : a publication of the Protein Society.

[27]  Yumi Akahori,et al.  Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[29]  Vikas Chandra,et al.  Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. , 2010, Annual review of physiology.

[30]  Lei Xu,et al.  The EDKB: an established knowledge base for endocrine disrupting chemicals , 2010, BMC Bioinformatics.

[31]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[32]  Wei Xu,et al.  Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. , 2011, Chemical research in toxicology.

[33]  Jean-Luc Pons,et al.  Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes , 2012, Proceedings of the National Academy of Sciences.

[34]  Laura N. Vandenberg,et al.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.

[35]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[36]  Ivan Rusyn,et al.  Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches. , 2013, Toxicology and applied pharmacology.

[37]  Travis S. Hughes,et al.  Ligand-binding dynamics rewire cellular signaling via Estrogen Receptor-α , 2013, Nature chemical biology.

[38]  Kwang-Hwi Cho,et al.  A generalized G-SFED continuum solvation free energy calculation model , 2013, Proceedings of the National Academy of Sciences.

[39]  S. Khorasanizadeh,et al.  Understanding nuclear receptor form and function using structural biology. , 2013, Journal of molecular endocrinology.

[40]  W. Bourguet,et al.  Structural and Functional Profiling of Environmental Ligands for Estrogen Receptors , 2014, Environmental health perspectives.

[41]  M. Barron,et al.  Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  Sehan Lee,et al.  A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs , 2016, Journal of Computer-Aided Molecular Design.

[43]  Ruili Huang,et al.  CERAPP: Collaborative Estrogen Receptor Activity Prediction Project , 2016, Environmental health perspectives.